Related Experiment Video
Updated: May 30, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Pharmacologic anticoagulation reversal in the emergency department
Stephen J Lemon1, Andrew J Crannage
1Department of Pharmacy, Cleveland Clinic, Ohio, USA. lemons@ccf.org
Abstract:
Anticoagulation therapies are 1 of the most commonly encountered therapeutic areas by health care professionals each day. One of the most important adverse effects of anticoagulation therapy is life-threatening hemorrhage, and it may result in visits to the emergency department. Some of the common reversal agents include Vitamin K, protamine sulfate, desmopressin, recombinant Factor VIIa, and prothrombin complex concentrates. Each of these agents has the potential to reverse specific anticoagulation therapies, but each agent has a unique administration procedure and monitoring parameters. However, these agents are not without risk of adverse effects. Knowledge of unique aspects of each reversal agent and the anticoagulation therapy must be considered when selecting or recommending pharmacologic anticoagulation reversal therapy. The intent of this review is to discuss the relevant management issues associated with anticoagulant reversal in the emergency department.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management
Cardiopulmonary Resuscitation IV: Pharmacological Management
